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Abstract
Objective: Evidence is accumulating that synovial tissue plays an active role in osteoarthritis (OA), however, exact
understanding of its contribution is lacking. In order to further elucidate its role in the OA process, we aimed to identify the
secretion pattern of soluble mediators by synovial tissue and to assess its ability to initiate cartilage degeneration.
Methods: Synovial tissue explants (STEs) obtained from donors without history of OA (n = 8) or from end stage OA patients
(n = 16) were cultured alone or together with bovine cartilage explants in the absence or presence of IL-1a. The secretion of
48 soluble mediators was measured and the effect on glycosaminoglycan (GAG) release and matrix metalloproteinase
(MMP) activity was determined.
Results: Normal and OA STEs secreted comparable levels of almost all measured soluble mediators. However, in the
presence of IL-1a these mediators were less secreted by OA than by normal STEs of which 15 differed significantly (p,0.01).
No effect of normal or OA STEs on GAG release from the cartilage explants was observed, and no differences in MMP activity
between OA and normal STEs were detected.
Conclusions: Unexpectedly, a comparable secretion profile of soluble mediators was found for OA and normal STEs while
the reduced responsiveness of OA STEs to an inflammatory trigger indicates a different state of this tissue in OA patients.
The effects could be the result of prolonged exposure to an inflammatory environment in OA development. Further
understanding of the pro-inflammatory and inflammation resolving mechanisms during disease progression in synovial
tissue may provide valuable targets for therapy in the future.
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Introduction
Osteoarthritis (OA) is one of the most frequently occurring
rheumatic diseases. In Western populations OA is by far the most
common form of joint disease, causing pain, loss of function and
disability [1]. The main characteristic of the disease is progressive
loss of articular cartilage, which is thought to be due to an
imbalanced interplay between anabolic, anti-catabolic, anti- and
pro-inflammatory and anti- and pro-apoptotic activities [2,3].
Numerous risk factors for OA have been identified, however, the
exact etiology, pathogenesis and progression of this disease have
yet to be determined [4]. As a consequence of the limited
understanding of the disease complexity, no disease modifying
treatments are currently available. The only existing therapeutic
strategies are primarily aimed at reducing pain and improving
joint function.
Traditionally, research on knee OA has been focused on
cartilage degradation. Nowadays, however, it is generally accepted
that the entire joint organ including synovium, synovial fluid, bone
and infrapatellar fat pad can contribute to the disease [5].
Inflammation, classically seen as a characteristic for rheumatoid
arthritis (RA), has lately also been recognized for its role in OA
development [6,7]. Inflammation of the synovium (synovitis) has
been shown to occur in a number of knee OA patients [8] and
may produce proteases and cytokines that contribute to the
disease. However, its role in the onset and progression in OA has
yet to be elucidated.
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It has been suggested that activated synovial macrophages
might play a key role in the processes leading to synovial
inflammation. This inflammation may act as a trigger for several
symptoms of OA via release of soluble mediators by synovium,
thus contributing to the breakdown of cartilage by promoting
destruction and impairing the ability of repair [6]. The cytokines
interleukin (IL)-1b and tumor necrosis factor (TNF)-a are likely to
be one of those soluble mediators [9]. The understanding of the
role of synovium and inflammation in the process of OA
development could provide leads for new targets for OA
treatment.
Based on published literature we hypothesized that synovium
from OA patients is more inflamed than synovium of normal
donors and therefore plays an active role in the breakdown of
cartilage. To provide insight in this hypothesis, synovial tissue
explants (STEs) of normal donors and OA patients were collected
and analyzed for the spontaneous secretion of soluble mediators as
well as their response to a pro-inflammatory trigger which was
expected to be more increased in OA STEs than in normal STEs.
We also used a complex in vitro co-culture model in which STEs
were cultured together with cartilage explants in a Transwell
system to assess the ability of STEs to initiate degeneration of
healthy cartilage.
Methods
STEs Collection
Synovium of the knee was obtained from post-mortem material of
8 donors with macroscopically healthy cartilage and no history of
OA (normal STE), or from material obtained during joint
replacement surgery of 16 OA patients (OA STE) (Articular
Engineering, Northbrook, USA). Human tissues were obtained
according to legal and ethical requirements approved by the
institutional review board of the University of Pennsylvania
including anonymous informed written consent from the donor
or nearest relative. Normal donors’ age ranged from 18–67 years
and body mass index (BMI) from 19–37. OA donors’ age ranged
from 43–70 and BMI from 18–47. Within 24 hours, synovial tissue
was carefully excised from surrounding fat. Explants of 3 mm in
size and a weight of 2263.5 mg were placed in a 48-wells plate in
Iscove’s Modified Dulbecco’s Medium (IMDM, Invitrogen,
Paisley, UK) containing 10% v/v fetal calf serum (FBS)
(GibcoBRL, Invitrogen) and 1% v/v of 10,000 units/ml Penicil-
lin:10,000 units/ml streptomycin (Penstrep) (Biowhittaker, Ver-
viers, Belgium). STEs were placed at 4uC until the start of the
experiment. STEs were placed for 1 hour at 37uC in a humidified
atmosphere of 5% CO2 in air before the start of the experiment.
Immunohistochemistry of STEs
From each donor one STE was directly frozen in Tissue Tek
O.C.T. compound (Sakura Finetek, Zoeterwoude, the Nether-
lands) and cut into 5 mm slices using a cryotome. Samples were
thawed for 30 minutes and blocked with PBS containing 5%
bovine serum albumin (BSA) (Sigma-Aldrich, St. Louis, USA).
Sections were incubated overnight at 4uC with antibody CD68-
biotin (mouse IgG2b 1:750) (E-bioscience, San Diego, USA). The
next day sections were washed with PBS and blocked for 5 minutes
with peroxidase (Dako, Heverlee, Belgium). After a final wash step
in PBS, sections were incubated with Novared for 10 minutes and
counterstained with heamatoxylin. As a negative control an
isotype matched control antibody was used (IgG2b-biotin, BD).
STEs Culture
As a reflection of the whole synovium, for each condition 6
STEs from different anatomical locations in the joint per donor
were cultured in a 24 wells plate in 700 ml Dulbecco’s Modified
Eagle Medium (DMEM) (Invitrogen) supplemented with Insulin-
transferrin-sodium selenite (ITS) (Roche Diagnostics, Basel,
Switzerland), 1% v/v Penstrep, 1 mg/ml lactalbumin and 5 mg/
ml vitamin C (Sigma-Aldrich) (serum free medium) and were
incubated with or without 10 ng/ml IL-1a (Peprotech, Rocky Hill,
USA). After 3 and 5 days 350 ml medium was refreshed and
stored. After 7 days all medium was collected. Pooled supernatant
samples were made representing the average of 6 different STEs
per donor and the production over a time period of 7 days. All
samples were stored at 280uC.
Multiplex ELISA Assay
By using 2 commercial kits (42- human cytokine-plex and 11-
human adipokine-plex, catalogue number: MPXHCY-
TO60KPMX42 and HADCYT-61K-11, Millipore, Billerica,
USA) a wide panel of soluble mediators was measured in pooled
supernatants of the STEs cultured alone. These assays were
performed with Luminex xMap Technology (Qiagen, Billerica,
USA) according to the manufacturer’s instructions. Liquichip
analyzer software (Qiagen) was used for data analysis.
Preparation of Cartilage Explants
Due to the availability and heterogeneity of human cartilage
explants, standardization for in vitro models is difficult and
therefore we used bovine cartilage explants [10–12]. Cartilage
from the metacarpophanlangeal joints of 6 months old calves was
obtained on the day of slaughter. Permission of the slaughterhouse
(Ton Boer en zn., Nieuwerkerk a/d IJssel, the Netherlands) to use
these joints in this experiment was given. Joints were aseptically
opened and cartilage explants were obtained by using a biopsy
punch of 4 mm. The cartilage explants were cultured in serum
free medium overnight at 37uC in a humidified atmosphere of 5%
CO2 in air.
STE-cartilage Co-culture
Co-culturing of cartilage explants and STEs was performed in
a 24-wells polycarbonate Transwell system with a pore size of
0.4 mm (Corning Incorporated, NY, USA). Each well contained
a cartilage punch in the lower compartment and a STE in the
upper compartment in 700 ml serum free medium with or without
10 ng/ml human IL-1a. Six STEs per donor per condition were
used. As a control, cartilage was cultured alone. After 3 and 5 days
350 ml medium was refreshed and stored. After 7 days all medium
was collected. Pooled supernatant samples were made representing
the average of 6 different STEs per donor and the production over
a time period of 7 days. All samples were stored at 280uC.
Analysis of Glycosaminoglycans (GAGs)
Cartilage explants were digested 24 hours at 56uC in 3% v/v
papain from papaya latex, 5 mM cysteine HCL, 50 mM EDTA,
and 0.1 M sodium acetate (pH 5.53) (Sigma-Aldrich). The amount
of glycosaminoglycans (GAGs), reflecting the amount of proteo-
glycans, was determined in cartilage explants as well as in culture
medium using a commercial kit (Biocolor Ltd, Belfast, N. Ireland).
The total GAG content was calculated by summing the amount of
GAGs in the cartilage explant and the culture medium. Pro-
teoglycan degradation was expressed as the percentage of GAG
release into the medium compared to the total GAG content.
Responsiveness of Osteoarthritis Synovial Tissue
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Analysis of Matrix Metalloproteinase (MMP) Activity
Secreted MMP activity was assessed in the culture medium
using a fluorogenic substrate as described previously [13]. The
secreted MMP activity was calculated by determining the
difference in substrate conversion in the presence or absence of
MMP inhibitor BB94 (10 mM). This approach detects only MMP-
mediated substrate conversion and reflects the MMP activity in the
culture conditions.
Data Analysis
Statistical analyses were performed using SPSS software version
17.0. Individual differences were tested by non-parametric Mann-
Whitney tests. For comparisons of normal and OA STEs in the co-
culture conditions, the GAG release of the cartilage explants were
subtracted from the co-culture condition to correct for differences
in bovine donors (D). Differences were considered statistically
significant at p,0.01 for the Multiplex Elisa data. This cut-off was
chosen to reduce the chance of false-positives, since a large
number of variables were tested in a relative small number of
donors due to the uniqueness of this material. For GAG release
and MMP activity significance levels were set at p,0.05.
Results
Secretion of Soluble Mediators by STEs
To assess differences between normal and OA STEs 48 soluble
mediators were measured in the pooled supernatants. Without IL-
1a stimulation, only 5 soluble mediators were secreted at
significantly different levels (p,0.01). Remarkably, these media-
tors were excreted at a lower level by OA STEs than normal STEs
(Figure 1A).
Under pro-inflammatory (IL-1a-stimulated) conditions 15 of the
measured mediators were significantly less secreted by OA STEs
than by normal STEs (p,0.01). Of these 15 mediators, 4 were also
significantly different in the absence of IL-1a (Figure 1B). IL-13,
IL-17, IL-2, IL-4, IL-9, PDGF-AB, TGFa, TNF-b and IL-12p70
could not be detected in either condition.
To assess the response to an inflammatory trigger of STEs from
normal and OA donors, soluble mediator excretion levels were
analyzed in both the non-stimulated and the IL-1a-stimulated
condition. For normal STEs, 16 mediators increased significantly
(p,0.01) after stimulation with IL-1a (Figure 2A). Unexpectedly,
the STEs obtained from OA donors secreted only 3 mediators at
a significantly different level after IL-1a stimulation (Figure 2B).
An overview of all measured mediators in these supernatants can
be consulted in table S1.
Immunohistochemistry on one STE from each donor showed
well known characteristics of OA such as hyperplasia as observed
by an increase in cell number and thickening of the synovial layer.
CD68+ cells were present in both OA and normal STEs,
indicating the presence of synovial macrophages during the
culture period (Figure S1).
Co-culture Effects on GAG-release and MMP-activity in
Cartilage Explants
Based on multiplex analysis we questioned if there was also
a different effect of normal and OA STEs on cartilage
degradation. Hereto, we used an in vitro co-culture model in
which cartilage explants were cultured together with STEs. Co-
culturing with normal or OA STEs did not induce additional
GAG release above the basal release of cartilage explants in non-
and IL-1a-stimulated culture conditions (Figure 3). IL-1a stimu-
lation led to significantly more GAG release in all culture
conditions (table 1). When comparing absolute values, normal
and OA donors differed significantly, however, this was due to
a significant difference in basal release of the cartilage explants and
not for additional GAG release induced by STEs (indicated in
table 1 by the calculated delta (D)).
To assess for collagen degrading enzymes, MMP activity was
measured in the different culture conditions. Remarkably, the
MMP activity in the medium of non-stimulated normal and OA
STEs cultured alone was significantly higher than in the co-
cultures (p,0.01, Figure 4A,C). This was also observed for the IL-
1a-stimulated OA condition (Figure 4D; p,0.05). A trend was
observed in the IL-1a-stimulated normal condition (Figure 4B;
p,0.1). IL-1a stimulation did not led to significantly more MMP
activity when normal or OA STE was cultured alone (table 2). IL-
1a stimulation yielded significantly more MMP activity in the co-
cultures with OA STE while this was not the case for normal STE
culture conditions. This is probably due to the fact that bovine
cartilage donors used in the OA STE conditions were more prone
to IL-1a stimulation with respect to MMP activity than those used
in normal STE conditions (table 2).
Discussion
Increasing evidence indicates that inflammation of the syno-
vium is a feature of OA associated with the progression of disease
[6]. It remains, however, unclear in which way alterations in the
synovium contribute to degenerative processes in the cartilage. By
measuring the secretion of soluble mediators by the synovium and
investigate its effect on cartilage break-down, we hoped to identify
new mechanisms in OA and to provide new targets to intervene in
the disease process. Unexpectedly, STEs from end stage OA
patients showed comparable secretion levels as normal STEs for
a wide panel of soluble mediators, suggesting that the in-
flammatory state of end stage OA-derived synovium is not
different from normal. Differences between normal and end-stage
OA STEs appeared after stimulation with IL-1a showing a di-
minished responsiveness of OA compared to normal STEs.
Furthermore, STEs derived from end stage OA patients did not
induce more GAG release from healthy cartilage explants or
displayed more MMP activity than normal STEs in the presence
or absence of a pro-inflammatory trigger. This suggests that
synovium from end stage OA patients is not, or no longer capable
of initiating cartilage degradation.
With regard to OA, the pro-inflammatory cytokines IL-1b and
TNFa are most frequently studied and detected. Furthermore
IFN-c, IL-2, IL-4, IL-6, IL-8, TGFb and IL-10 have received
attention as important cytokines in the OA process [14–17]. Of
these soluble mediators all, except IL-2, were secreted by STEs.
Unexpectedly, IL-1a, one of the key cytokines in the pathogenesis
of OA [18], was significantly less secreted by end stage OA STEs
than by normal STEs.
The unexpected effects in mediator release and on GAG release
seen in our study could be explained by the state of the STEs. All
OA STEs were obtained from OA patients undergoing joint
replacement surgery and are therefore in the end stage of the
disease. Originally, it was thought that the condition of the
synovium was correlated with OA severity and occurred gradually
through the disease process [19,20]. However, Roemer et al.
showed that baseline joint effusion and synovitis predicted the risk
of cartilage loss after 30 months follow up [21]. This indicates an
important role for inflammation in an earlier stage of OA.
Furthermore, Benito et al. demonstrated that early OA synovium
has more features of inflammation (greater cell infiltration and
overexpression of inflammatory mediators) than late OA synovium
[8]. In line with this, Ning et al. found a decreased expression of
Responsiveness of Osteoarthritis Synovial Tissue
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MMP-1, COX-2 and IL-1b expression in synovium depending
upon the severity of OA [17]. These previous observations are in
agreement with our result that end stage OA STEs display an
excretion profile that is rather similar to that of normal controls.
The occurrence of inflammation resolving mechanisms in end
stage OA STEs due to exposure to inflammatory triggers earlier in
life might explain this observation. This is substantiated by its
diminished responsiveness to a pro-inflammatory trigger. Potential
molecular mechanism would be the down regulation of many
receptors and a decreased secretion of resolving mediators to
counter balance chronic inflammation. The fact that MMP
activity seemed to be down regulated when co-cultured with
cartilage explants also contributes to this idea. Furthermore, end-
stage OA STEs were not able to induce cartilage degeneration in
a co-culture model which endorses the idea that synovium is not
capable of initiating cartilage degradation. However, it does not
rule out the possibility that it plays a role in progression and
aggravation of the cartilage destruction process in OA, since we
have not tested OA and normal STEs on OA-derived cartilage.
Beekhuizen et al. have demonstrated in a comparable in vitro co-
culture model with matched OA cartilage and OA STEs an effect
on GAG production, but not on GAG release [22]. Due to our
Figure 1. Soluble mediator secretion by normal and OA synovial tissue explants (STEs) with or without IL-1a. Graphs demonstrate all
soluble mediators which were significantly (p,0.01) different between A. normal (black bars) and OA (grey bars) STEs and B. normal and OA STEs
under pro-inflammatory (IL-1a) conditions. Data were obtained from pooled supernatants representing the average of 6 STEs per donor and the
production in a time period of 7 days. Data are plotted on a log scale. Bars indicate mean concentration (pg/ml culture medium) 6 SD.
doi:10.1371/journal.pone.0062634.g001
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Figure 2. Soluble mediator secretion by non-stimulated and stimulated synovial tissue explants (STEs) from normal and OA
donors. Graphs demonstrate the absolute levels of all soluble mediators, which were significantly (p,0.01) different between A. non-stimulated
(black bars) and IL-1a-stimulated (white bars) normal STEs and B. non-stimulated (grey bars) and IL-1a-stimulated (white bars) OA STEs. Data were
obtained from pooled supernatants representing the average of 6 STEs per donor and the production in a time period of 7 days. Data are plotted on
a log scale. Bars indicate mean concentration (pg/ml culture medium) 6 SD.
doi:10.1371/journal.pone.0062634.g002
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design, we were not able to determine GAG synthesis by, for
example, the rate of sulphate incorporation. However, based on
total GAG content (data not shown) we do not expect an effect of
OA or normal STEs on GAG synthesis.
Remarkably, it seems that IL-1a is not involved in the activation
of STEs leading to cartilage destruction, since no increase in GAG
release was observed even though numerous soluble mediators
were elevated. The effect of the IL-1a trigger on GAG release and
MMP activity can be subscribed to its direct effect on
Table 1. Percentage GAG release from cartilage explants cultured alone or together with STEs under non-stimulated and IL-1a-
stimulated conditions.
Condition % GAG release P-values
Normal
Normal
(IL-1a) OA OA (IL-1a)
Normal vs
Normal (IL-1a)
OA vs OA
(IL-1a) Normal vs OA
Normal (IL-1a)
vs OA (IL-1a)
Cartilage 18.6 (2.6) 43.1 (9.3) 21.5 (3.4) 54.9 (4.7) 0.002 0.000 0.026 0.005
STE+cartilage 18.2 (2.5) 45.1 (8.8) 19.6 (3.5) 54.8 (8.1) 0.002 0.000 0.245 0.032
D STE+cartilage 20.32 (2.9) 1.95 (2.5) 21.9 (3.0) 20.15 (6.4) 0.180 0.576 0.245 0.267
%GAG release is indicated as mean (SD).
D STE+cartilage: corrected value for GAG release in the cartilage explant.
doi:10.1371/journal.pone.0062634.t001
Figure 3. Proteoglycan degradation of healthy cartilage explants cultured alone or together with synovial tissue explants (STEs).
Proteoglycan degradation was expressed as the percentage of glycosaminoglycans (GAG) released into the medium during 7 days of culture of
cartilage alone or co-cultured together with normal (A, B) or OA (C, D) STEs without (A, C) or with (B, D) IL-1a stimulation. Each line represents an
individual donor and connects the % GAG release of cartilage alone (left) with the matching co-culture condition of cartilage together with STEs
(right). There were no significant differences between cartilage cultured alone or co-cultured with normal or OA STEs.
doi:10.1371/journal.pone.0062634.g003
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chondrocytes without any contribution of IL-1a- stimulated STEs.
However, other explanations could be that IL-1a overrules the
effect of the secreted soluble mediators or not all human mediators
excreted by STEs cross-react with bovine receptors.
Minor points of the study need to be addressed. As the excretion
of soluble mediators is not corrected for the amount of cells, the
absolute levels can be discussed. To reach feasible standardization
in this experiment the results were based on multiple explants per
Table 2. Secreted MMP activity (rfu/sec) by STE and cartilage alone and by the co-culture of STE and cartilage under non-
stimulated and Il-1a-stimulated conditions.
Condition Secreted MMP-activity (rfu/sec) P-values
Normal
Normal
(IL-1a) OA OA (IL-1a)
Normal vs
Normal (IL-1a)
OA vs OA
(IL-1a) Normal vs OA
Normal (IL-1a)
vs OA (IL-1a)
Cartilage 0.003 (0.003) 0.009 (0.007) 0.003 (0.006) 0.023 (0.018) 0.170 0.000 0.232 0.007
STE 0.081 (0.039) 0.196 (0.314) 0.115 (0.098) 0.280 (0.343) 0.898 0.245 0.596 0.244
STE+cartilage 0.021 (0.006) 0.047 (0.045) 0.042 (0.048) 0.126 (0.212) 0.174 0.004 0.121 0.061
Secreted MMP activity is indicated as mean (SD).
doi:10.1371/journal.pone.0062634.t002
Figure 4. Secreted MMP activity of STEs and cartilage explants cultured alone or together. After 7 days, the MMP-activity (rfu/sec) was
determined (in culture medium) of normal (A, B) and OA (C, D) STEs and healthy cartilage explants, cultured alone or together, without (A, C) or with
(B, D) IL-1a stimulation. Each line represents an individual donor and demonstrates the activity of STEs alone (left), STEs together with cartilage
explants (middle) or cartilage explants cultured alone (right). The MMP activity in the medium of STEs cultured alone was higher, compared to the
MMP activity in the co-culture conditions. Significance levels are indicated.
doi:10.1371/journal.pone.0062634.g004
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donor with comparable weights. Furthermore, the presence of
small pieces of other tissues as well as the injury response at
collection cannot be fully excluded. At last, we cannot exclude that
hypoxia in post mortem obtained normal STEs influenced the
outcome of the study although hypoxia inducible factor-driven
VEGF levels were not different between normal and OA STEs
[23,24]. Due to the fact that the procedures for OA and normal
STEs were standardized we expect that the observed differences
include comparable limitations.
In summary, we found the excretion profile of OA STEs to be
comparable to that of normal donors. This is in contrast to what
we had anticipated, namely more inflamed tissue with elevated
secretion of pro-inflammatory mediators and MMPs. As such it is
understandable that no contribution of the OA STEs was observed
on cartilage destruction in the co-culture model. The responsive-
ness of the STEs to a pro-inflammatory trigger, however, indicates
that there are differences in the state of the tissue between OA and
normal donors. It suggests that end stage OA STEs are less
sensitive to inflammatory stimulation which might be due to
prolonged exposure to an inflammatory environment during
disease progression. However, this does not rule out the
involvement of STEs in an earlier phase of OA development.
Further understanding of the pro-inflammatory and inflammation
resolving mechanisms during disease progression in synovium may
provide valuable targets for therapy in the future.
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